Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue - Other
Ratios

Perspective Therapeutics (CATX) Other Gross PP&E Adjustments (2016 - 2025)

Perspective Therapeutics' Other Gross PP&E Adjustments history spans 15 years, with the latest figure at $68.0 million for Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments rose 55.94% year-over-year to $68.0 million; the TTM value through Sep 2025 reached $68.0 million, up 55.94%, while the annual FY2024 figure was $56.6 million, 947.04% up from the prior year.
  • Other Gross PP&E Adjustments for Q3 2025 was $68.0 million at Perspective Therapeutics, up from $65.3 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $68.0 million in Q3 2025 and bottomed at $296000.0 in Q4 2022.
  • The 5-year median for Other Gross PP&E Adjustments is $13.8 million (2023), against an average of $22.8 million.
  • The largest annual shift saw Other Gross PP&E Adjustments plummeted 96.6% in 2022 before it skyrocketed 1727.03% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $8.7 million in 2021, then tumbled by 96.6% to $296000.0 in 2022, then surged by 1727.03% to $5.4 million in 2023, then soared by 947.04% to $56.6 million in 2024, then increased by 20.11% to $68.0 million in 2025.
  • Per Business Quant, the three most recent readings for CATX's Other Gross PP&E Adjustments are $68.0 million (Q3 2025), $65.3 million (Q2 2025), and $62.9 million (Q1 2025).